November-19: Around the World
- Posted by CERC India
- Posted in monthly, November-2019
AUSTRALIA
Misleading advertisements prevalent in Tourism
What you see, is not what you get
You expect to enjoy the scenic beauty that is shown in the pictures that you see in travel magazines or tourism advertisements. Imagine when you reach the place and realise it is nothing like the picture. Tourism promoters are increasingly being caught out for using the wrong photo to advertise a destination.
Incidences have been reported where travellers who have uploaded the photos of a destination have found the same photos being used to promote a different place, says www.abc.net.au.
University of Technology, Sydney tourism lecturer David Beirman said that these recent cases, false advertising in the industry had become less widespread. “In the 1990s, you were often relying on printed material or brochures. It’s a bit harder to get away with it these days, mainly because tour operators know that their customers can very easily check out the veracity of a photo.
Consumer beware
USA
Coffee does not pose serious cancer threat
Grab a coffeeÂ
California state has declared that coffee does not pose a “significant” cancer risk and thus will not have to carry warnings. Under a law passed more than three decades ago by California voters, products that contain chemicals that cause cancer or birth defects must warn consumers about those risks. The safety of coffee has been in dispute in California since a state court judge ruled in March 2018 that coffee must carry a cancer warning because of the presence of acrylamide, a potentially carcinogenic chemical created during the roasting process.
The Office of Environmental Health Hazard Assessment, which implements the law, concluded there was no significant risk after a World Health Organization review of more than 1000 studies and found inadequate evidence that coffee causes cancer.
No major worry
USA
Eye scan can help early detection of Alzheimer’s
Window to health
 New research affirms a correlation between the speed of pupil dilation and the earliest stage of Alzheimer’s disease, before cognitive decline appears. Researchers from the San Diego School of Medicine are suggesting Alzheimer’s disease may be detected years before symptoms appear by examining pupil dilation. The new study reveals measuring the speed of pupil dilation while a person undertakes a cognitive test could help identify early stages of Alzheimer’s.
A large number of healthy middle-aged adults were administered cognitive tests. Their pupillary responses were then measured against genetic risk scores for Alzheimer’s. The results confirmed an association between the two factors.
Early detection helps
Â
